New malaria tool shows which kids at greatest risk

May 8, 2013
Karl Seydel, MSU assistant professor of osteopathic medical specialties, cares for a child with malaria in Blantyre, Malawi. Seydel and colleagues discovered a test that can help clinicians make crucial decisions about which malaria patients face the greatest risk for developing a life-threatening form of the disease. Credit: Photo by Jim Peck.

Researchers at Michigan State University have identified a test that can determine which children with malaria are likely to develop cerebral malaria, a much more life-threatening form of the disease.

The could be a game-changer in resource-limited rural health clinics where workers see hundreds of children with malaria each day and must decide which patients can be sent home with oral drugs and which need to be taken to hospitals for more comprehensive care.

"Rural have to make these decisions with very little objective data, and the consequences of an inappropriate decision are huge," said Karl Seydel, MSU assistant professor of osteopathic medical specialties. "Children who progress to have a 20 percent mortality rate, or even higher if they don't get the right treatment early in the disease process."

In a new study in the Journal of Infectious Diseases, Seydel and colleagues report that testing patients' blood for HRP2—a protein produced by the – was an accurate predictor of how the disease progressed among children at Central Hospital in Blantyre, Malawi.

"We found that if HRP2 levels are low, clinicians can be more than 98 percent sure the child will not progress to cerebral malaria," Seydel said. "That would give them the confidence to merely prescribe oral drugs and send the child home."

Nowhere is the need for such a tool greater than in Africa, where 90 percent of childhood malaria deaths occur. Only about 1 percent of children with malaria develop the life-threatening form of the disease, yet an estimated 1 million African children die from it each year.

"In most of Africa, where resources are still so limited, using those available resources appropriately and intelligently is of great importance," Seydel said.

The HRP2 test in its current form is costly and poorly suited to use in rural clinics, Seydel noted. He and colleagues are in the process of developing a less expensive, more portable version.

Seydel's collaborators on the study include MSU researchers Lindsay Fox, Terrie Taylor and Mathew Reeves, along with partners from the University of Malawi College of Medicine.

Explore further: Drug could reverse scourge of cerebral malaria for survivors

Related Stories

Drug could reverse scourge of cerebral malaria for survivors

May 1, 2012
Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral ...

Research team launches groundbreaking drug trial in Africa

February 16, 2013
Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.